COLDA 2020 is set up as an exclusive virtual platform that aims at providing a unique opportunity for clinicians, researchers, policymakers, industry, and other healthcare professionals in the African region. They will be supported by an international community of experts in the exchange of knowledge on the latest clinical developments and updates on ongoing and new trials in liver disease tailored to local needs. In turn, this will lead to strengthening the local experts’ capacity in the field of liver disease. Liver disease in light of the COVID-19 pandemic will be discussed. 

The program will include materials in both English and French. 


COLDA will be a scientific, abstract-driven, highly educational regional 2.5-day virtual conference comprised of:

  • State-of-the-art lectures
  • Keynote speeches
  • Case presentations
  • Abstract presentations
  • Round-table discussions
  • Debates
  • Symposia sessions
  • Q&A

Topic Highlights

  • Viral hepatitis infections
  • Hepatitis co-infections
  • Non-viral hepatitis-related infections
  • Non-infectious induced liver disease
  • Hepatocellular carcinoma (HCC)
  • End-stage liver disease
  • NASH
  • Diagnostics

More information will be announced soon. 

Click here to view the program of COLDA 2019: COLDA PROGRAM